Advertisement

Restriktive Kardiomyopathie

  • M. Böhm

Zusammenfassung

Die restriktive Kardiomyopathie ist eher selten und zeichnet sich durch eine zunehmende Steifigkeit des Herzens mit Beteiligung des Myokards, des Intertitiums und des Endokards aus (Kushawa et al. 1997). Die Steifigkeit kann durch eine vermehrte endomyokardiale Fibrosierung, aber auch durch Einlagerung von Proteinen (z. B. Amyloid) bedingt sein. Das Ausmaß der hämodynamischen Beeinträchtigung korreliert nicht zwingend mit den histopathologisch beobachteten Veränderungen (Keren u. Popp 1992).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abel:ram: 5111, Lorell 1111 (1989)’ The challenge of cardiomyopathy. AIO Coll Cordiol 13: 1219-1239Google Scholar
  2. Arnold M McGrire L, Lee JC (1988) Loefflers fibroplaslic endocar tilt’s. Pathology 20: 79 82Google Scholar
  3. Berger PB, Doffy J, Reeder (.5 et aI. (1994) Restrictive eardiumyopahc arto, idled with the eosinophilia nlyalgia,,yndromc. Mayo (~ lin Pro, 09: 1(, 2 11, 5Google Scholar
  4. Cecchetti G, Binda A, Piperno A et al. (1991) Cardiac alterations in 36 consecutive patients with idiopathic hemochromatosis: polygraphic and echocardiographic evaluation. Eur Heart J 12: 224 - 230PubMedGoogle Scholar
  5. Cetta F, OLeary PW, Seward JB, Driscoll DJ (1995) Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 7o: 634 - 640Google Scholar
  6. Chidiac TA, Bukowski RM, Klein AL et al. (1997) High dose intensive dexamethasone and interferon-alpha in primary amyloidosis: clinical resulta. Am Soc Clin Oncol: V16 - 12aGoogle Scholar
  7. Child JS, Perloff JK (1988) The restrictive cardiomyopathies. Cardiol Clin 6: 289 - 316PubMedGoogle Scholar
  8. Fausi AS, Harley JB, Roberts WC et al. (1982) The hypereosinophilic syndrome: clinical pathophysiologic, and therapeutic considerations. Ann Intern Med 97: 78 - 92CrossRefGoogle Scholar
  9. Felice PV, Sawicki J, Anto J (1993) Endomyocardial disease and eosinophilia. Angiology 44: 869-874Google Scholar
  10. Fitzpatrick AP, Shapiro LM, Richards AF, Poole-Wilson PA (1990) Familial restrictive cardiomyopathy with atrioventricular block and skeletal myopathy. Br Heart J 63: 114 - 118PubMedCrossRefGoogle Scholar
  11. Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: Response and survival in 64 patients. Medicine (Baltimore) 7o: 246 - 252Google Scholar
  12. Gross DM, Williams JC, Caapriolo C et al. (1988) Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol 61: 170 - 176PubMedCrossRefGoogle Scholar
  13. Katritsis D, Wilmshurst PT, Wendon JA et al. (1991) Primary restrictive cardiomyopathy: clinical and pathologie characteristics. J Am Coll Cardiol 18: 1230 - 1235PubMedCrossRefGoogle Scholar
  14. Keren A, Popp RL (1992) Assignment of patients into the classification of cardiomyopathies. Circulation 86: 1622 - 1633PubMedCrossRefGoogle Scholar
  15. Klein AL, Hatle LK, Taliercio CP et al. (1991) Prognostic significance of doppler measures of diastolic function in cardiac amyloidosis. A doppler echocardiography study. Circulation 83: 808-816Google Scholar
  16. Kushawa SS, Fallon JT, Fuster V (1997) Restrictive Cardiomyopathy. N Engl J Med 336: 267 - 276CrossRefGoogle Scholar
  17. Kyle RA, Gertz MA, Greipp PR et al. (1997) A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 336: 1202 - 1207PubMedCrossRefGoogle Scholar
  18. Kyle RA, Gertz MA, Greipp PR et al. (1993) Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis. Am J Hematol 44: 125 - 128PubMedCrossRefGoogle Scholar
  19. Leung DY, Klein AL (1997) Restrictive cardiomyopathy. Diagnosis and progrostic implications. In: Otto CM (ed) Practice of clinical echocardiography. Saunders, PhiladelphiaGoogle Scholar
  20. Lewis AB (1992) Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 123: 1589-1593Google Scholar
  21. Mc Manus BM, Bren GB, Robertson EA (1981) Hemodynamic cardiac constriction without anatomic myocardial restriction or pericardial constriction. Am Heart J 102: 134 - 136CrossRefGoogle Scholar
  22. Olsen EGJ, Spry CFJ (1985) Relation between eosinophilia and endomyocardial disease. Frog Cardiovasc Dis 27: 241 - 254CrossRefGoogle Scholar
  23. Parillo JE (1990) Heart disease and the eosinophil. N Engl J Med 323: 1560 - 1561CrossRefGoogle Scholar
  24. Ruvers H, Garrahy P, Robinson W, Murphy A (1987) Reversible car- diac dysfunction in hemochromatosis. Am Heart J 113: 216-217 Saraiva MJ (1995) Transthyretin mutations in health and disease. Hum Mutat 5:191-196Google Scholar
  25. Shabetai R (1992)Controversial issues in restrictive cardiomyopathy. Postgrad Med J 68: 47-51Google Scholar
  26. Sharma OP (1994) Myocardial sarcoidosis. A wolf in sheeps clothing (editorial; comment). Chest 106: 988 - 990PubMedCrossRefGoogle Scholar
  27. Skinner M, Anderson JJ, Simms R el al. (1996) Treatment of on patients with primary amyloidisis; a randomized trial of melphaIan, prednisone, and colchicine vs. colchicine alone. Am J Med 100: 290 - 298Google Scholar
  28. Spyrou N, Foale I((1994) Restrictive cardiomyopathies. Curr Opin Cardiol 9:344 348 Google Scholar
  29. von Scheidt W, Fng CM, l-itzmaurice TF et al. (1991) An atypical variant of Fabrys disease with manifestation confined to the myocardium N lrigl J Med 324: 395-399Google Scholar
  30. Weller l’F, liubley (iJ (1994) ‘The idiopathic hypereosinophilic syndrome. Blood 8): 2759 2779Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • M. Böhm

There are no affiliations available

Personalised recommendations